Aug 2026· Cell Biochemistry and Biophysics· Vol 84, pp. 4435 - 4448· 0 citations· 28 references
Medicine
TL;DR
ARAP3 promotes glioma progression and is sustained by IGF2BP3-mediated m6A-dependent mRNA stabilization, highlighting the IGF2BP3–ARAP3 axis as a potential biomarker and therapeutic target.
Gliomas, the most prevalent primary malignant brain tumors, are characterized by highly invasive growth patterns. Emerging evidence indicates that long non-coding RNAs are essential for regulating key oncogenic pathways. This study focuses on lncRNA LAMTOR5 antisense RNA AS1 (LAMTOR5-AS1, also known as SLC16A4-AS1), se...
Jia-Yi Li, Jing Li, Lin Yu· Neoplasma (Bratislava)· 0 citations
Silencing of TMEM33 markedly suppresses CRC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) both in vitro and in vivo, and significantly reduces subcutaneous tumor growth and pulmonary metastatic burden.
Rui Li, Li Zhao, Nan-Nan Chai et al.· Human Cell· 0 citations
This study reveals for the first time the complete molecular mechanism by which ZCCHC4-mediated UHRF1 m6A methylation promotes OS progression through epigenetic suppression of CDO1 transcription and inhibition of ferroptosis.
Kai Song, Ju Liu, Bo-Wen Han et al.· Bone· 0 citations
Results showed that PARP2 was highly expressed in hepatocellular carcinoma and related to its poor prognosis, and METTL3-mediated PARP2 m6A modification plays a vital tumor-promoter role in hepatocellular carcinoma progression.
Meng-Ke Li, Yan Zhao, Yuan Li· Toxicology and Applied Pharm...· 0 citations
Temozolomide (TMZ) resistance remains a major obstacle to effective glioblastoma (GBM) treatment and is closely linked to enhanced DNA damage repair. Kinesin family member 4A (KIF4A) has been implicated in tumor progression, but its role in TMZ resistance remains unclear. In this study, KIF4A and TAR DNA-binding protei...